Source: BioPortfolio

RadiaDyn: AngioDynamics to Acquire RadiaDyne and its Revolutionary OARtrac Radiation Dose Monitoring Platform to Further Expand Oncology Portfolio

AngioDynamics Inc. NASDAQANGO a leading provider of innovative minimally invasive medical devices for vascular access peripheral vascular disease and oncology today announced an agreement to acquire RadiaDyne a privately held medica...

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
100-250
John Isham's photo - Founder & CEO of RadiaDyn

Founder & CEO

John Isham

CEO Approval Rating

81/100

Read more